Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
CareDx, Inc. (CDNA) Hit a 52 Week High, Can the Run Continue?
10:15am, Friday, 09'th Aug 2024
CareDx (CDNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CareDx (CDNA) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:00pm, Wednesday, 07'th Aug 2024
CareDx (CDNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics
09:05pm, Wednesday, 31'st Jul 2024
The headline numbers for CareDx (CDNA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
CareDx, Inc. (CDNA) Q2 2024 Earnings Call Transcript
08:03pm, Wednesday, 31'st Jul 2024
CareDx, Inc. (NASDAQ:CDNA ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Greg Chodaczek - Managing Director John Hanna - President and CEO Abhishek Jain - Chief Finan
CareDx (CDNA) Q2 Earnings and Revenues Beat Estimates
07:05pm, Wednesday, 31'st Jul 2024
CareDx (CDNA) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.18 per share a year ago.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA)
10:30am, Tuesday, 16'th Jul 2024
NEW YORK , July 16, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating CareDx, Inc. (NASDAQ: CDNA) on behalf of the company's shareholders. The investigation seeks to de
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
07:05am, Thursday, 30'th May 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of cl
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
08:05am, Wednesday, 29'th May 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
CareDx to Participate in Upcoming Investor Conferences
07:05am, Wednesday, 29'th May 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clini
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of cl
CareDx, Inc. (CDNA) Q1 2024 Earnings Call Transcript
10:42pm, Thursday, 09'th May 2024
CareDx, Inc. (NASDAQ:CDNA ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Greg Chodaczek - Managing Director of Investor Relations John Hanna - President & Chief Executi
CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Thursday, 09'th May 2024
Although the revenue and EPS for CareDx (CDNA) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street e
CareDx Reports First Quarter 2024 Results
04:05pm, Thursday, 09'th May 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Reported first quarter rev
CareDx (CDNA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:20am, Tuesday, 07'th May 2024
Beyond analysts' top -and-bottom-line estimates for CareDx (CDNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
